Freezing Human Eggs for In Vitro Fertilization No Longer Experimental Procedure
By Margaret Warner,
PBS Newshour
| 10. 19. 2012
[with CGS's Marcy Darnovsky]
Watch Freezing Human Eggs for In Vitro No Longer Experimental on PBS. See more from PBS NewsHour.
Transcript
MARGARET WARNER: We turn to new guidelines and questions surrounding freezing eggs to treat infertility.
Doctors started freezing and then thawing eggs for in vitro fertilization, or IVF, years ago, but in very few cases, and the procedure has been considered experimental.
Today, the American Society for Reproductive Medicine shifted its position, saying the process shouldn't be labeled experimental any longer. It said babies born from frozen eggs are as healthy as those from fresh eggs. But the committee said the procedure should be limited in its use.
It's estimated there have only been about 1,000 births from frozen eggs, compared to nearly five million babies born through traditional IVF.
We look at what's changed and the thicket of questions it raises now with Dr Eric Widra. He co-chaired the committee that made the recommendation change. He's with the Shady GroveFertilityCenter.
And Marcy Darnovsky is the associate executive director of the Center for Genetics and Society in Berkeley, Calif.
Welcome, both of...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...